Advertisement
Home 2016 September

Monthly Archives: September 2016

Use of nonsurgical therapy is increasing for advanced-stage oral cavity squamous cell carcinoma

Nonsurgical Therapy Increasing for Advanced Oral Cavity SCC

Surgical therapy linked to significantly improved mean disease-specific and overall survival
Among men with intermediate-risk prostate cancer

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer
For women with cervical and endometrial cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm
Wary of the stigma of a mental health diagnosis and its toll on their careers

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests
For patients with mild-to-moderate psoriasis

Long-Term Tx Adherence Low in Mild-to-Moderate Psoriasis

Internet-based reporting intervention improves adherence to treatment with topical fluocinonide
Cesarean section (CS) is associated with increased risk of postpartum venous thromboembolism

Review Links C-Section With Increased Risk of Postpartum VTE

Meta-analysis shows increased risk is greater after emergency cesarean than after elective cesarean
Infants born with cleft lip

No Long-Term Health Issues for Infants With Isolated Oral Clefts

However, cleft palate associated with increased risk for developmental problems
For patients with heart failure

T2DM Predicts Mortality in Patients With Heart Failure

Type 2 diabetes mellitus predicts mortality, regardless of presence of ischemic heart disease
For men who have sex with men and are receiving HIV medical care

Unmet Needs for Non-HIV Care in Men Who Have Sex With Men

About 23 percent have unmet need for dental care, 19 percent have unmet need for eye or vision care
For patients with type 2 diabetes mellitus

Changes in Use of Glucose-Lowering Drugs From 2006-2013

Increase in metformin, DPP-4 inhibitors, insulin use; decrease in sulfonylureas and thiazolidinediones